NYSE · Analyst Forecast

Bio-Rad Laboratories, Inc. (BIO.B) Stock Forecast & Price Target

$389.98 NYSE: BIO.B Market Cap $10.43B

Price as of Nov 17, 2026 close · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Bio-Rad Laboratories, Inc. (BIO.B), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

No analyst estimates are published for this stock. Coverage is concentrated in larger companies.

Analyst forecasts for other Medical - Devices stocks

ABT forecastISRG forecastMDT forecastSYK forecastBSX forecastEW forecastRMD forecastDXCM forecastPHG forecastZBH forecastAll Medical - Devices stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNYSE High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.